Microneedle-Mediated Transdermal and Intradermal Drug Delivery

Microneedle-Mediated Transdermal and Intradermal Drug Delivery

Volumn , Issue , 2012, Pages

  Donnelly, Ryan F ^a   Singh, Thakur Raghu Raj ^a   Morrow, Desmond I J ^a   Woolfson, A David ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891582704     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119959687     Document Type: Book

References (462)

1. Scheuplein, R.J., and I.H. Blank (1971) Permeability of the skin. Physiol. Rev. 51, 702-747.
2. Smith, H.W., H.A. Clawes, and E.K. Marshall (1919) The mechanism of absorption by the skin. J Pharmacol. 13, 1-30.
3. Scheuplein, R.J. (1967) Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 48, 79-88.
4. Chuong, C.M., B.J. Nickoloff, P.M. Elias, L.A. Goldsmith, E. Macher, P.A. Maderson, J.P. Sundberg, H. Tagami, P.M. Plonka, K. Thestrup-Pedersen, B.A. Bernard, J.M. Schroder, P. Dotto, C.H. Chang, M.L. Williams, K.R. Feingold, L.E. King, A.M. Kligman, J.L. Rees, and E. Christophers (2002) What is the 'true' function of skin? Viewpoint. Exp. Dermatol. 11, 159-163.
5. Claudy, A.L. (1986) The dermo-epidermal junction. Annales de Dermatologie et de Venereologie 113, 1161-1166.
6. Reaven, E.P., and A.J. Cox (1965) Histidine and keratinisation. J. Invest. Dermatol. 45, 422-431.
7. Wiechers, J.W. (1989) The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm. Weekbld. Sci. Ed. 11, 185-198.
8. Michaels, A.S., S.K. Chandrasekaran, and J.E. Shaw (1975) Drug permeation through human skin: Theory and in vitro experimental measurement. AlCHE Journal 21, 985-996.
9. Benson, H.A.E. (2005) Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Del. 2, 23-33.
10. Menon, G.K. (2002) New insights into skin structure: scratching the surface. Adv. Drug Deliv.Rev. 54, S3-S17.
11. Williams, A.C., and B.W. Barry (2004) Penetration enhancers. Adv. Drug Deliv. Rev. 56, 603-618.
12. Jensen, J.M., and E. Proksch (2009) The skin's barrier. Giornale Italiano di Dermatologia e Venereologia 144, 689-700.
13. Asbill, C.S., A.F. El-Kattan, and B. Michniak (2000) Enhancement of transdermal drug delivery: chemical and physical approaches. Crit.Rev. Ther. Drug Carrier Syst. 17, 621-658.
14. Bouwstra, J.A., G.S. Gooris, J.A. van der Spek, and W. Bras (1991) Structural investigations of human stratum corneum by small-angle X-ray scattering. J Invest Dermatol. 97, 1005-1012.
15. Singh, S., and J. Singh (1993) Transdermal drug delivery by passive diffusion and iontophoresis: a review. Med.Res.Rev. 13, 569-621.
16. Meidan, V.M. (2010) Methods for quantifying intrafollicular drug delivery: a critical appraisal. Expert Opinion on Drug Delivery 7, 1095-1108.
17. Tobin, D.J. (2006) Biochemistry of human skin - our brain on the outside. Chemical Society Reviews 35, 52-67.
18. Flynn, G.L. (1979) Topical drug absorption and topical pharmaceutical systems. In: Banker, G.R., and G.L. Rhodes (eds) Modern Pharmaceutics, Marcel Dekker, New York, pp. 263-327.
19. Scheuplein, R.J. (1976) Percutaneous absorption after twenty five years or 'Old wine in new wineskins'. J. Invest. Dermatol. 67, 31-38.
20. Blank, I.H. (1965) Cutaneous barriers. J. Invest. Dermatol. 45, 249-256.
21. Stoughton, R.B. (1972) Some bioassay methods for measuring skin absorption. Adv. Biol. Skin 12, 535-546.
22. Scheuplein, R.J. (1972) Properties of the skin as a membrane. Adv. Skin Biol. 12, 125-152.
23. Flynn, G.L., S.H. Yalkowsky, and T.J. Roseman (1974) Mass transport phenomena and models: theoretical concepts. J. Pharm. Sci., 63, 479-510.
24. Brown, L., and R. Langer (1988) Transdermal delivery of drugs. Am. Rev. Med. 39, 221-229.
25. Wiechers, J.W., and R.A. De Zeeuw (1990) Transdermal drug delivery: efficacy and potential applications of the penetration enhancer Azone. Drug Des. Del. 6, 87-100.
26. Kumar, R., and A. Philip (2007) Modified transdermal technologies: Breaking the barriers of drug permeation via the skin. Tropical J. of Pharm. Res. 6, 633-644.
27. Subedi, R.K., S.Y. Oh, M.K. Chun, and H.K. Choi (2010) Advances in transdermal drug delivery. Archives of Pharmacal Research 33, 339-351.
28. Aggarwal, G., A. Garg, and S. Dhawan (2009) Transdermal drug delivery: evolving technologies and expanding opportunities. Indian J. of Pharm. Educ. and Res. 43, 251-259.
29. Baroli, B. (2010) Penetration of nanoplarticles and nanomaterials in the skin: fiction or reality? J. of Pharm. Sci. 99, 21-50.
30. Sun, F., R. Anderson, and G. Aguilar (2010) Stratum corneum permeation and percutaneous drug delivery of hydrophilic molecules enhanced by cryopneumatic and photopneumatic technologies. J. of Drugs in Dermatology 9, 1528-1530.
31. Smith, N.B. (2008) Applications of ultrasonic skin permeation in transdermal drug delivery Expert Opinion on Drug Delivery 5, 1107-1120.
32. Polat, B.E., D. Blankschtein, and R. Langer (2010) Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs. Expert Opinion on Drug Delivery 7, 1415-1432.
33. Merino, G., Y.N. Kalia, and R.H. Guy (2003) Ultrasound-enhanced transdermal transport. J Pharm Sci. 92, 1125-1137.
34. Lavon, I., and J. Kost (2004) Ultrasound and transdermal drug delivery. Drug Discov Today 9, 670-676.
35. Mitragotri, S., D. Blankschtein, and R. Langer (1995) Ultrasound-mediated transdermal protein delivery. Science 269, 850-853.
36. Park, E.J., J. Werner, and N.B. Smith (2007) Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm. Res. 24, 1396-1401.
37. Mitragotri, S. (2005) Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Re.v Drug Discov. 4, 255-260.
38. Singer, A.J., C.S. Homan, A.L. Church, and S.A. McClain (1998) Low-frequency sonophoresis: pathologic and thermal effects in dogs. Acad. Emerg. Med. 5, 35-40.
39. Barry, B.W. (2001) Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14, 101-114.
40. Batheja, P., R. Thakur, and B. Michniak (2006) Transdermal iontophoresis. Expert Opin. Drug Deliv. 3, 127-138.
41. Kalia, Y.N., A. Naik, J. Garrison, and R.H. Guy (2004) Iontophoretic drug delivery. Adv Drug Deliv Rev. 56, 619-658.
42. Wang, Y., R. Thakur, Q. Fan, and B. Michniak (2005) Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm. 60, 179-191.
43. Dixit, N., V. Bali, S. Baboota, A. Ahuja, and J. Ali (2007) Iontophoresis - an approach for controlled drug delivery: a review. Curr. Drug Deliv. 4, 1-10.
44. Sung, K.C., J.Y. Fang, J.J. Wang, and O.Y. Hu (2003) Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur J Pharm Sci. 18, 63-70.
45. Bachhav, Y.G., S. Summer, A. Heinrich, T. Bragagna, C. Bohler, and Y.N. Kalia (2010) Effect of controlled laser microporation on drug transport kinetics into and across the skin. J. of Cont Rel 146, 31-36.
46. Burkoth, T.L., B.J. Bellhouse, G. Hewson, D.J. Longridge, A.G. Muddle, and D.F. Sarphie (1999) Transdermal and transmucosal powdered drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 16, 331-384.
47. Roberts, L.K., L.J. Barr, D.H. Fuller, C.W. McMahon, P.T. Leese, and S. Jones (2005) Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 23, 4867-4878.
48. Dean, H.J., and D. Chen (2004) Epidermal powder immunisation against influenza. Vaccine 23, 681-686.
49. Wolf, A.R., P.A. Stoddart, P.J. Murphy, and M. Sasada (2002) Rapid skin anaesthesia using high velocity lignocaine particles: a prospective placebo controlled trial. Arch. Dis. Child. 86, 309-312.
50. Arora, A., I. Hakim, J. Baxter, R. Rathnasingham, R. Srinivasan, D.A. Fletcher, and S. Mitragotri (2007) Needle-free delivery of macromolecules across the skin by nanoliter- volume pulsed microjets. Proc. Natl. Acad. Sci. USA 104, 4255-4260.
51. Mitragotri, S. (2006) Innovation - Current status and future prospects of needle-free liquid jet injectors. Nature Reviews Drug Discovery 5, 543-548.
52. Benedek, K., E. Walker, L.A. Doshier, and R. Stout (2005) Studies on the use of needle- free injection device on proteins. J. Chromatogr. A. 1079, 397-407.
53. Houtzagers, C.M., A.P. Visser, P.A. Berntzen, R.J. Heine, and E.A. van der Veen (1988) The Medi-Jector II: efficacy and acceptability in insulin-dependent diabetic patients with and without needle phobia. Diabet. Med. 5, 135-138.
54. Henry, S., D.V. McAllister, M.G. Allen, and M.R. Prausnitz (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87, 922-925.
55. Hilt, J.Z., and N.A. Peppas (2003) Microfabricated drug delivery devices. Int J. Pharm. 306, 15-23.
56. Tao, S.L., and T.A. Desai (2003) Microfabricated drug delivery systems: from particles to pores. Adv. Drug Deliv. Rev. 55, 315-328.
57. Ito, Y., E. Hagiwara, A. Saeki, N. Sugioka, and K. Takada (2006) Feasibility of microneedles for percutaneous absorption of insulin. Eur. J. Pharm. Sci. 29, 82-88.
58. Ito, Y., J. Yoshimitsu, K. Shiroyama, N. Sugioka, and K. Takada (2006) Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J. Drug Target. 14, 255-261.
59. Wang, P.M., M. Cornwell, J. Hill, and M.R. Prausnitz (2006) Precise microinjection into skin using hollow microneedles. J. Invest Dermatol. 126, 1080-1087.
60. Kolli, C.S., and A.K. Banga (2008) Characterization of solid maltose microneedles and their use for transdermal delivery. Pharmaceutical Research 25, 104-113.
61. Miyano, T., Y. Tobinaga, T. Kanno, Y. Matsuzaki, H. Takeda, M. Wakui, and K. Hanada (2005) Sugar micro needles as transdermic drug delivery system. Biomed. Microdevices 7, 185-188.
62. McAllister, D.V., P.M. Wang, S.P. Davis, J.H. Park, P.J. Canatella, M.G. Allen, and M.R. Prausnitz (2003) Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci USA. 100, 13755-13760.
63. Park, J.H., M.G. Allen, and M.R. Prausnitz (2005) Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Cont Rel. 104, 51-66.
64. Park, J.H., M.G. Allen, and M.R. Prausnitz (2006) Polymer microneedles for controlled- release drug delivery. Pharm. Res. 23, 1008-1019.
65. Perennes, F., B. Marmiroli, M. Matteucci, M. Tormen, L. Vaccari, and E. Di Fabrizio (2006) Sharp beveled tip hollow microneedle arrays fabricated by liga and 3d soft lithography with polyvinyl alcohol. J. Micromech. Microeng. 16, 473-479.
66. Kaushik, S., A.H. Hord, D.D. Denson, D.V. McAllister, S. Smitra, M.G. Allen, and M.R. Prausnitz (2001) Lack of pain associated with microfabricated microneedles. Anesth. Analg. 92, 502-504.
67. Donnelly, R.F., T.R.R. Singh, and A.D. Woolfson (2010) Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Delivery 17, 187-207.
68. Prausnitz, M.R. (2004) Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56(5), 581-587.
69. Gerstel, M.S., and V.A. Place (1976) Drug Delivery Device, in US Patent US39644821976.
70. Henry, S., D.V. McAllister, M.G. Allen, et al. (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 87(8), 922-925.
71. Moon, S.J., S.S. Lee, H.S. Lee, et al. (2005) Fabrication of microneedle array using LIGA and hot embossing process. Microsystem Technologies 11(4-5), 311-318.
72. Hashmi, S., G. Hashmi, M. Reed, et al. (1995) Genetic transformation of nematodes using arrays of micromechanical piercing structures. Biotechniques 19(5), 766-770.
73. McAllister, D.V., P.M. Wang, S.P. Davis, et al. (2003) Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. PNAS 100(24), 13755-13760.
74. Miyano, T., Y. Tobinaga, K. Takahiro, et al. (2005) Sugar micro needles as transdermic drug delivery system. Biomedical Microdevices 7(3), 185-188.
75. Park, J.H., M.G. Allen, and M.R. Prausnitz (2005) Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 104(1), 51-66.
76. Ito, Y., Y. Jun-Ichiro, S. Keiji, et al. (2006) Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target 14(5), 255-261.
77. Park, J.H., M.G. Allen, and M.R. Prausnitz (2006) Polymer microneedles for controlled-release drug delivery. Pharm Res 23(5), 1008-1019.
78. Perennes, F., B. Marmiroli, M. Matteucci, et al. (2006) Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol. J Micromech Microeng 16(3), 473-479.
79. Ovsianikov, A., B. Chichkov, P. Mente, et al. (2007) Two photon polymerization of polymer-ceramic hybrid materials for transdermal drug delivery. Int J Applied Ceramic Tech 4(1), 22-29.
80. Verbaan, F.J., S.M. Bal, D.J.B. Van den, et al. (2007) Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J Control Release 117(2), 238-245.
81. Kolli, C.S., and A.K. Banga (2008) Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm Research 25(1), 104-113.
82. Donnelly, R.F., D.I.J. Morrow, T.R.R. Singh, et al. (2009) Processing difficulties and instability of carbohydrate microneedle arrays. Drug Devel Indus Pharmacy 35(10), 1242-1254.
83. Trichur, R., S. Kim, Zhu, et al. (2002) Development of plastic microneedles for transdermal interfacing using injection molding techniques. Micro Total Analysis System 1, 395-397.
84. Yang, M., and J.D. Zahn (2004) Microneedle insertion force reduction using vibratory actuation. Biomed Microdevices 6(3), 177-182.
85. Davis, S.P., W. Martanto, M.G. Allen, et al. (2005) Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng 52(5), 909-915.
86. Stoeber, B., H. Zhai, D. Liepmann, et al. (2005) Does tape-stripping of the stratum corneum enhance microneedle penetration for transdermal drug delivery? J Invest Dermatology 124(4), A35.
87. Donnelly, R.F., T.R.R. Singh, and A.D. Woolfson (2010) Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety. Drug Delivery 17(4), 187-207.
88. Sivamani, R.K., D. Liepmann, and H.I. Malbach (2007) Microneedles and transdermal applications. Expert Opinion Drug Deliv 4(1), 19-25.
89. Jing, J., E.H.T. Francis, Jianmin, et al. (2006) Microfabricated silicon microneedle array for transdermal drug delivery. J Physics: Conference Series. International MEMS Conference, 34, 1127-1131.
90. Katsuma, S., and G. Tsujimoto (2001) Genome medicine promised by microarray technology. Expert Rev Mol Diagn 1(4), 377-382.
91. Lindner, D., (2001) Microsystems for chemical and biological applications. MRS Bull, 26, 333-336.
92. Leoni, L., and T.A. Desai (2004) Micromachined biocapsules for cell-based sensing and delivery. Adv Drug Deliv Rev 56(2), 211-229.
93. Tao, S.L., and T.A. Desai (2003) Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev 55(3), 315-328.
94. Hilt, J.Z., and N.A. Peppas (2005) Microfabricated drug delivery devices. Int J Pharm 306(1-2), 15-23.
95. Zafar, S.R., P.K. Thwar, M. Yang, et al. (2004) Integrated microsystems for controlled drug delivery. Adv Drug Deliv Rev 56(2), 185-198.
96. Madou, M.J. (1997) Lithography. In: Madou MJ (ed.) Fundamentals of Microfabrication: The Science of Miniaturization, 2nd edn, CRC, Boca Raton, pp. 1-71.
97. Banks, D. (2006) Microengineering, MEMS, and Interfacing A Practical Guide. Taylor & Francis, Boca Raton, CRC.
98. Metz, T.E., R.N. Savage, and H.O. Simmons (1992) In situ control of photoresist coating process. Semicond. Int. 15, 68-72.
99. Moreau, W.M. (1988) Semiconductor Lithography. Lithography.
100. Jensen, K.F. (1989) Chemical vapor deposition. In: Hess DW, Jensen KF (eds) Microelectronics Processing: Chemical Engineering Aspects. American Chemical Society, Washington DC, pp. 199-264.
101. Adams, A.C. (1998) Dielectric and polysilicon film deposition. In: Sze SM (ed.) VLSI Technology. McGraw-Hill, New York, pp. 233-271.
102. Kern, W. (1978) Chemical etching of silicon, Germanium, gallium, arsenide, and gallium phosphide. RCA Rev. 39, 278-308.
103. Shikida, M., K. Sato, and K. Tokoro (2000) Differences in anisotropic etching properties of KOH and TMAH solutions. Sens Actuators A: Physical 80(2), 179-188.
104. McAllister, D.V., M.G. Allen, and M.R. Prausnitz (2000) Microfabricated microneedles for gene and drug delivery. Annu Rev Biomed Eng 2, 289-313.
105. Arduino, M.J., L.A. Bland, L.E. Danzig, et al. (1997) Microbiologic evaluation of needleless and needle-access devices. Am J Infect Control 25(5), 377-380.
106. Mukerjee, E., S.D. Collins, R.R. Isseroff, et al. (2004) Microneedle array for transdermal biological fluid extraction and in situ analysis. Sens Actuators A: Physical 114 (2-3), 267-275.
107. Wilke, N., A. Mulcahy, S.R. Ye, et al. (2005) Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectronics J 36, 650-656.
108. Paik, S.J., B. Sangwon, J.M. Lim, et al. (2004) In-plane single-crystal-silicon microneedles for minimally invasive microfluid systems. Sens Actua A: Physical. 114, 276-284.
109. Roxhed, N., P. Griss, and G. Stemme (2008) Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery. Biomedical Microdevices 10(2), 271-279.
110. Roxhed, N., B. Samel, L. Nordquist, et al. (2008) Painless drug delivery through microneedle-based transdermal patches featuring active infusion. IEEE Transac Biomed Eng 55(3), 1063-1071.
111. Rodriguez, A., D. Molinero, E. Valera, et al. (2005) Fabrication of silicon oxide microneedles from macroporous silicon. Sens Actuators B: Chemical 109(1), 135-140.
112. Bin, M., L. Sheng, and G. Zhiyin (2006) A PZT insulin pump integrated with a silicon microneedle array for transdermal drug delivery. Microfluid Nanofluid 2(5), 417-423.
113. Ashraf, M.W., S. Tayyaba, A. Nisar, et al. (2010) Design, fabrication and analysis of silicon hollow microneedles for transdermal drug delivery system for treatment of hemodynamic dysfunctions. Cardiovascular Eng 10(3), 91-108.
114. Ramasubramanian, M.K., O.M. Barham, and V. Swaminathan (2008) Mechanics of a mosquito bite with applications to microneedle design. Bioinspiration Biomimetics, 3(4), 1-10.
115. Banga, A.K. (2009) Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv 6(4), 343-354.
116. Chandrasekaran, S., and A.B. Frazier (2002) Mechanical characterization of surface micromachined microneedle array. 2nd Annual International IEEE-Embs Special Topic Conference on Microtechnologies in Medicine & Biology, Proceedings, 94-98.
117. Chandrasekaran, S., S.K. Mohanty, and A.B. Frazier (2003) Autonomous microneedle system for biochemical analysis. Boston Transducers'03: Digest of Technical Papers, 1 & 2, 1442-1445.
118. Verbaan, F.J., S.M. Bal, D. Van den, et al. (2007) Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human der- matomed skin. J Contr Rel 117, 238-245.
119. Trimmer, W., P.L. Chin, P. Orten, et al. (1995) Injection of DNA into plant and animal tissues with micromechanical piercing structures. of DNA into plant and animal tissues with micromechanical piercing structures.
120. Runyan, W.R., and Bean K.E. (1990) Semiconductor Integrated Circuit Processing Technology, Addison-Wesley, New York.
121. Braybrook, J.H., (1997) Assessment of Medical Devices and Materials, John Wiley & Sons, Inc., New York.
122. Dean, C.H., J.B. Alarcon, A.M. Waterston, et al. (2005) Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccine. 1(3), 106-111.
123. Alarcon, J.B., A.W. Hartley, N.G. Harvey, et al. (2007) Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 14(4), 375-381.
124. Wu, X.M., H. Todo, and K. Sugibayashi (2007) Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J Control Release 118(2), 189-195.
125. Badran, M.M., J. Kuntsche, and A. Fahr (2009) Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: Dependency on needle size and applied formulation. Europ J Pharma Sci 36(4-5), 511-523.
126. Martanto, W., S.P. Davis, N.R. Holiday, et al. (2004) Transdermal delivery of insulin using microneedles in vivo. Pharm Res. 21(6), 947-952.
127. Saluja, S.K.N., A. Badkar, and A.K. Banga (2009) Optimization of fabrication of in-plane titanium microneedles. of fabrication of in-plane titanium microneedles.
128. Cormier, M., B. Johnson, M. Ameri, et al. (2004) Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Rele 97(3), 503-511.
129. Martanto, W., S.P. Davis, R.H. Nicholas, et al. (2006) Microinfusion using hollow microneedles. Pharm Res 23(1), 104-113.
130. Lee, K., H.C. Lee, D.C. Lee, et al. (2010) Drawing lithography: Three-dimensional fabrication of an ultrahigh-aspect-ratio microneedle. Adv Materials 22(4), 483-487.
131. Down, J.A., and N.G. Harvey (2003) Minimally invasive systems for transdermal drug delivery, In Guy RH, Hadgraft J (eds) Transdermal Drug Delivery. Marcel Dekker, New York, pp. 327-360.
132. Aoyagi, S., I. Hayato, I. Yuichi, et al. (2007) Laser fabrication of high aspect ratio thin holes on biodegradable polymer and its application to a microneedle. Sens Actuators A: Physical 139(1-2), 293-302.
133. Lee, J.W., J.H. Park, and M.R. Prausnitz (2008) Dissolving microneedles for transdermal drug delivery. Biomaterials 29(13), 2113-2124.
134. Lippmann, J.M., E.J. Geiger, and A.P. Pisano (2007) Polymer investment molding: Method for fabricating hollow, microscale parts. Sens Actuators A: Physical 134, 2-10.
135. Han, M., D.K. Kim, H.K. Seong, et al. (2009) Improvement in antigen-delivery using fabrication of a grooves-embedded microneedle array. Sens Actuators B-Chemical 137(1), 274-280.
136. Sammoura, F., J.J. Kang, Y.M. Heo, et al. (2007) Polymeric microneedle fabrication using a microinjection molding technique. Microsyst Technol 13(5-6), 517-522.
137. Gomaa, Y.A., D.I.J. Morrow, M.J. Garland, et al. (2010) Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: Assessments by transepidermal water loss. Toxicol in Vitro 24(7), 1971-1978.
138. Sullivan, S.P., D.G. Koutsonanos, M. del Pilar Martin, et al. (2010) Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16(8), 915-920.
139. Miyano, T., T. Miyachi, T. Okanishi, et al. (2007) Hydrolytic microneedles as transdermal drug delivery system. microneedles as transdermal drug delivery system.
140. Ito, Y., H. Eiji, S. Atsushi, et al. (2006) Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharma Sci 29(1), 82-88.
141. Ito, Y., A. Murakami, T. Maeda, et al. (2008) Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats. Int J Pharm 349(1-2), 124-129.
142. Kwon, S.Y., and S.J. Oh (2009) In vitro and in vivo transdermal PTH delivery by a dissolving micro-needle patch. vitro and in vivo transdermal PTH delivery by a dissolving micro-needle patch.
143. Kwon, S.Y., (2004) In vitro evaluation of transdermal drug delivery by a microneedle patch. vitro evaluation of transdermal drug delivery by a microneedle patch.
144. Chu, L.Y., S.O. Choi, and M.R. Prausnitz (2010) Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs. J Pharma Sci 99(10), 4228-4238.
145. Park, J.H., S.O. Choi, R. Kamath, et al. (2007) Polymer particle-based micromolding to fabricate novel microstructures. Biomed Microdevices 9(2), 223-234.
146. Han, M., D.H. Hyun, H.H. Park, et al. (2007) A novel fabrication process for out-ofplane microneedle sheets of biocompatible polymer. J Micromecha Microeng 17(6), 1184-1191.
147. Chun, K., G. Hashiguchi, H. Toshiyoshi, et al. (1999) An array of hollow microcapillaries for the controlled injection of genetic materials into animal/plant cells. In IEEE MEMS Conference Proceedings, Orlando.
148. Gardeniers, H.J.G.E., R. Luttge, E.J.W. Berenschot, et al. (2003) Silicon micromachined hollow microneedles for transdermal liquid transport. J Microelectromech Sys 12(6), 855-862.
149. Matteucci, M., M. Fanetti, M. Casella, et al. (2009) Poly vinyl alcohol re-usable masters for microneedle replication. Microelectronic Eng 86(4-6), 752-756.
150. Gittard, S.D., A. Ovsianikov, N.A. Monteiro-Riviere, et al. (2003) Fabrication of polymer microneedles using a two-photon polymerization and micromolding process. J Diabetes Sci Technol 3(2), 304-311.
151. Sullivan, S.P., N. Murthy, and M.R. Prausnitz (2008) Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Materials 20(5), 6-10.
152. Donnelly, R.F., M.J. Garland, D.I.J. Morrow, et al. (2010) Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J Control Release 147(3), 333-341.
153. Hong, G., A.S. Holmes, M.E. Heaton, et al. (2003) Design, fabrication and characterization of an axial-flow turbine for flow sensing. Proceedings of MEMS.
154. Zhu, X., J.W. Choi, R. Cole, et al. (2002) A new laser micromachining technique using a mixed-mode ablation approach. Proceedings of MEMS. pp. 152-155.
155. Davis, S.P., M.R. Prausnitz, and M.G. Allen (2003) Fabrication and characterization of laser micromachined hollow microneedles. Proceedings of Transducers. pp. 1435-1438.
156. Barrett, D.O., A. Maha, Y. Wang, et al. (2004) Design of a microfabricated device for the ligase detection reaction (LDR). Proceedings of ASME Int. Mechanical Engineering Congress and Exposition, 62111.
157. Donnelly, R.F, R. Majithiya, T.R.R. Singh, et al. (2011) Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res 28(1), 41-57.
158. Verbaan, F.J., S.M. Bal, D.J.B. Van den, et al. (2008) Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Release. 128, 80-88.
159. Kendalla, M.A.F., Y.F. Chong, and C. Alexander (2007) The mechanical properties of the skin epidermis in relation to targeted gene and drug delivery. Biomaterials. 28, 4968-4977.
160. Laurent, P., M. Frederic, B. David, et al. (2007) Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine. 25(34), 6423-6430.
161. Champion, R.H., J.L. Burton, B. Tony, et al. (1998) Anatomy of skin. In: Textbook of Dermatology, 6th edition. Wiley-Blackwell, Massachusetts.
162. Davidson, A., B. Al-Qallaf, and D.D. Bhusan (2008) Transdermal drug delivery by coated microneedles: geometry effects on effective skin thickness and drug permeability. Chem Eng Res Design. 86, 1196-1206.
163. Lv, Y.G., J. Lie, and B. Xu (2006) Modeling of transdermal drug delivery with a microneedle array. J. Micromech. Microeng 16, 2492-2501.
164. Teo, A.L., C. Shearwood, K.C. Ng, et al. (2006) Transdermal microneedles for drug delivery applications. Mater Sci Eng 132, 151-154.
165. Shikida, M., T. Hasada, and K. Sato (2006) Fabrication of a hollow needle structure by dicing wet etching and metal deposition. J Micromech Microeng 16, 2230-2239.
166. Stoeber, B., and D. Liepmann (2005) Arrays of hollow out-of-plane micro-needles for drug delivery. J Microelectromech Syst 14, 472-479.
167. Pastorin, G., H. Junginger, T.R. Nayak, and Z. Munrui (2009) Nanoneedles devices for transdermal vaccine delivery: in vitro and in vivo evaluation. Controlled Release Society Proceedings.
168. Al-Qallaf, B., and D.B. Das (2008) Optimization of square microneedle arrays for increasing drug permeability in skin. Chem Eng Sci 63, 2523-2535.
169. Al-Qallaf, B., and D.B. Das (2009) Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery. Ann NY Acad Sci 1161, 83-94.
170. Singh, T. R. R., M. J. Garland, C. M. Cassidy, et al. (2010) Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul 4(1), 1-17.
171. Donnelly, R. F., A. Morrissey, P. A. McCarron, et al. (2007) Microstructured devices for transdermal drug delivery and minimally-invasive patient monitoring. Recent Pat Drug Deliv Formul 1, 195-200.
172. Donnelly, R. F., T. R. R. Singh, D. A. Woolfson, (2010) Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety. Drug Deliv 17(4), 187-207.
173. Singh, T. R. R., R. Majithiya, D. A. Woolfson, et al. (2010) Microneedle-based transdermal drug delivery devices. PMPS August 48.
174. Verbaan, F.J., S.M. Bal, D.J. Van den Berg, et al. (2008) Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Rel 128, 80-88.
175. Verbaan, F.J., S.M. Bal, D.J. Van den Berg, et al. (2007) Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J Cont Rel 117, 238-245.
176. Lee, J., and S.H. Hong (2008) Microneedle roller. US20080161735.
177. Microneedle. http://www.microneedle.com/main/index.html (accessed on 23 January 2011).
178. Nanogen. http://www.nanogen.co.uk/scalproller-hair-loss-treatment-enhancer.html (accessed on 23 January 2011).
179. Cormier, M.J.N., W.A. Young, J.A. Johson, P.E. Daddona, and M. Ameri (2004/2006) Transdermal drug delivery devices having coated microprotrusions. WO2004002566 (2004) and US20060200069 (2006).
180. Trautman, J.C., and R.L. Keenan (2005) Microprotrusion member retainer for impact applicator. US6855131.
181. Zosanopharma. http://www.zosanopharma.com/. (Accessed on 23 January 2011).
182. Trautman, J.C., and L. Olson (2006) Self-actuating applicator for microprojection array. US7097631.
183. Trautman, J.C., R.W. Worsham, D.F. Bayramov, D.F. Bowers, S.R. Klemm, and P. Singh (2008) Applicators for microneedles arrays. US2008000824.
184. Corium International. http://www.coriumgroup.com/downloads/seriescpress release.pdf. Accessed online on 23 January 2011.
185. Gary, C. (2009) The emergence of active transdermal drug delivery; Controlled Release Society Annual Meeting. Copenhagen, Denmark, 18-22 July.
186. Clarke, G.M., M.D. Delmore, M.K. Domroese, R.H. Ferber, J.D. Jacobs, J.C. Keister, and F.L. Frederickson (2005) Microneedle devices and microneedle delivery apparatus. US0261631.
187. Ringsred, T.K., and F.L. Frederickson (2008) Microneedle array applicator and retainer. US20080009825.
188. Cantor, A.S. (2008) Non-skin-contacting microneedle array applicator. US20080009811.
189. Cantor, A.S., F.L. Frederickson, P.R. Johnson, and T.K. Ringsred (2008) Low-profile microneedle array applicator. US20080114298.
190. Simons, J.K., and F.L. Frederickson (2009) Device for applying a microneedle array. US20090198189.
191. Frederickson, F.L., M.D. Johnson, and D.J. Wirtanen (2008) Collapsible patch and method of application. US20080195035.
192. Prausnitz, M.R., M.G. Allen, S. Henry, D.V. McAllister, D.E. Ackley, and T. Jackson (2004) Devices and methods for enhanced microneedle penetration of biological barriers. US6743211.
193. Nanobiosciences. http://www.nanobiosciences.com/. Accessed online on 23 January 2011.
194. Yuzhakov, V.V. (2007/2010) Microneedle array, patch, and applicator for transdermal drug delivery. US20070161964 (2007) and US7658728 (2010).
195. Tobinaga, Y., and S. Sugiyama (2005) Applicator for applying functional substances into human skin. US20050065463.
196. Withey, E.L. (2007) High-speed vaccination device. US0106207.
197. Henley, J.L. (2007) Iontosonic-microneedle applicator apparatus and methods. US0276318.
198. Yeshurun, Y., Y. Levin, M. Hefetz, Y. Sefi, and G. Lavi (2009) Microneedle adaptor for dosed drug delivery devices. US20090247953.
199. Petits, R.J., F.E. Martin, and S.A. Chastener (2009) Microneedle-based pen device for drug delivery and method for using same. US7556615.
200. BD Available online at: http://www.bd.com/pharmaceuticals/products/micro injection.asp, Accessed online on 23 January 2011.
201. Laurent, A., F. Mistretta, D. Bottigioli, et al. (2007) Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 25, 6423-6430.
202. Laurent, P., B. Stephane, A. Paul, et al. (2007) Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. Vaccine 25, 8833-8842.
203. Eriksson, E., C. Baker, W.R. Allison, et al. (2008) Microseeding device for gene delivery by microneedle injection. US7422574.
204. Donnelly, R. F., M. J. Garland, D. I. J. Morrow, et al. (2010) Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J Control Release 147(3), 333-341.
205. Gomaa, Y. A., D. I. J. Morrow, M. J. Garland, et al. (2010) Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: Assessments by transepidermal water loss. Toxicol in Vitro 24, 1971-1978.
206. Nanogen. http://www.hairfantastic.co.uk/cart.php (Accessed on 14 January 2011).
207. Tobin, D.J. (2006) Biochemistry of human skin - our brain on the outside. Chem. Soc. Rev. 35, 52-67.
208. Wysocki, A.B. (1999) Skin anatomy, physiology, and pathophysiology. Nurs. Clin. North Am. 34, 777-797.
209. Asbill, C.S., A.F. El-Kattan, and B. Michniak (2000) Enhancement of transdermal drug delivery: Chemical and physical approaches. Crit. Rev. Ther. Drug Carrier Syst. 17, 621-658.
210. Chuong, C.M., B.J. Nickoloff, P.M. Elias, L.A. Goldsmith, E. Macher, P.A. Maderson, J.P. Sundberg, H. Tagami, P.M. Plonka, K. Thestrup-Pederson, B.A. Bernard, J.M. Schroder, P. Dotto, C.M. Chang, M.L. Williams, K.R. Feingold, L.E. King, A.M. Kligman, J.L. Rees, and E. Christophers (2002) What is the 'true' function of skin? Exp. Dermatol. 11, 159-187.
211. El-Kattan, A., C.S. Asbill, and S. Haidar (2000) Transdermal testing: Practical aspects and methods. Pharm. Sci. Technolo Today 3, 426-430.
212. Surber, C., and E.W. Smith (2005) The mystical effects of dermatological vehicles. Dermatology 210, 157-168.
213. Thomas, B.J., and B.C. Finnin (2004) The transdermal revolution. Drug Discov. Today. 9,697-703.
214. BNF No. 53 (2011) British National Formulary, BMJ Publishing Group Ltd, London.
215. Benson, H.A.E. (2005) Transdermal drug delivery: Penetration enhancement techniques. Curr Drug Del. 2, 23-33.
216. Yano, T., A. Nakagawa, M. Tsuji, and K. Noda (1986) Skin permeability of various non-steroidal anti-inflammatory drugs in man. Life Sci. 39, 1043-1050.
217. Funke, A.P., R. Schiller, H.W. Motzkus, C. Gunther, R.H. Muller, and R. Lipp (2002) Trans dermal delivery of highly lipophilic drugs: In vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations. Pharm. Res. 19, 661-668.
218. Williams, A.C. (2003) Transdermal and Topical Drug Delivery. and Topical Drug Delivery.
219. Hadgraft, J., and R. Guy (1989) Transdermal drug delivery. drug delivery.
220. Bronaugh, R.L., and H.I. Maibach (1989) Percutaneous Absorption, 2nd edn. Marcel Dekker, New York.
221. Wiechers, J.W. (1989) The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm. Weekbl. Sci. 11, 185-198.
222. Idson, B. (1975) Percutaneous absorption. J. Pharm. Sci. 64, 901-924.
223. Shore, P.A., B.B. Brodie, and C.A.M. Hogben (1957) The gastric secretion of drugs: A pH partition hypothesis, J. Pcol., Exp., Therap. 119, 361-369.
224. Hadgraft, J., J. du Plessis, and C. Goosen (2000) The selection of non-steroidal antiinflammatory agents for dermal delivery. Int. J. Pharm. 207, 31-37.
225. Watkinson, A.C., K.R. Brain, and K.A. Walters (1993) The penetration of ibuprofen through human skin in vitro: Vehicle, enhancer and pH effects. In: K.R. Brain, V. James, K.A. Walters (eds), Prediction of Percutaneous Permeation, Vol 3b, STS Publishing, Cardiff, pp. 335-341.
226. Hadgraft, J., and C. Valenta (2000) pH, pK(a) and dermal delivery. Int. J. Pharm. 200, 243-247.
227. Henry, S., D.V. McAllister, M.G. Allen, and M.R. Prausnitz (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87, 922-925.
228. Kaushik, S., A.H. Hord, D.D. Denson, D.V. McAllister, S. Smitra, M.G. Allen, and M.R. Prausnitz (2001) Lack of pain associated with microfabricated microneedles. Anesth. Analg. 92, 502-504.
229. Millard. D.R. Jr., and D.O. Maisels (1966) Silicon granuloma of the skin and subcutaneous tissues. Am. J. Surg. 112, 119-123.
230. Gill, H., and M. Prausnitz (2007) Coated microneedles for transdermal delivery. J. Control. Release 117, 227-237.
231. Gill, H., and M. Prausnitz (2007) Coating formulations for microneedles. Pharm. Res. 24(7), 1369-1280.
232. Mikszta, J.A., J.B. Alarcon, J.M. Brittingham, D.E. Sutter, R.J. Pettis, and N.G. Harvey (2002) Improved genetic immunization via micromechanical disruption of skinbarrier function and targeted epidermal delivery. Nat. Med. 8, 415-419.
233. Yan, G., K.S. Warner, J. Zhang, S. Sharma, and B.K. Gale (2010) Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery. Int. J. Pharm. 391, 7-12.
234. Wei-Ze, L., H. Mei-Rong, Z. Jian-Ping, Z. Yong-Qiang, H. Bao-Hua, L. Ting, and Z. Yong (2010) Super-short solid silicon microneedles for transdermal drug delivery applications. Int. J. Pharm. 389, 122-129.
235. Pearton, M., C. Allender, K. Brain, A. Anstey, C. Gateley, N. Wilke, A. Morrissey, and J. Birchall (2007) Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm. Res. 25, 407-416.
236. Martanto, W., S.P. Davis, N.R. Holiday, J. Wang, H.S. Gill, and M.R. Prausnitz (2004) Transdermal delivery of insulin using microneedles in vivo. Pharm. Res. 21, 947-952.
237. Badran, M.M., J. Kuntsche, and A. Fahr (2009) Skin penetration enhancement by a microneedle device (Dermaroller®) in vitro: Dependency on needle size and applied formulation. Eur. J. Pharm. Sci. 36, 511-523.
238. Banks, S.L., R.R. Pinninti, H.S. Gill, P.A. Crooks, M.R. Prausnitz, and A.L. Stinchcomb (2008) Flux across microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro. Pharm Res. 25, 1677-1685.
239. Milewski, M., T.R. Yerramreddy, P. Ghosh, P.A. Crooks, and A.L. Stinchcomb (2010) In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin. J Control Release 146(1), 37-44.
240. Wermeling, D.P., S.L. Banks, D.A. Hudson, H.S. Gill, J. Gupta, M.R. Prausnitz, and A.L. Stinchcomb (2008) Microneedles permit transdermal delivery of a skinimpermeant medication to humans. PNAS 105, 2058-2063.
241. McAllister, D., P. Wang, S. Davis, J. Park, P. Canatella, M. Allen, and M. Prausnitz (2003) Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. PNAS 100(24), 13755-13760.
242. Xie, Y., B. Xu, and Y. Gao, (2005) Controlled transdermal delivery of model drug compounds by MEMS microneedle array. Nanomed. Nanotechnol. 1(2), 184-190.
243. Chang, R.L., S.K. Moon, H.B. Lee, K.L. Han, M.R. John, and K. Gilson (2007) The effect of molecular weight of compounds on transdermal delivery system using microneedle device. Key Eng Mater. 342(3), 945-8.
244. Cormier, M., B. Johnson, M. Ameri, K. Nyam, L. Libiran, D. Zhang, and P. Daddona (2004) Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 97, 503-511.
245. Lin, W., M. Cormier, A. Samiee, A. Griffin, B. Johnson, C.L. Teng, G.E. Hardee, and P.E. Daddona (2001) Transdermal delivery of antisense oligonucleotides with microprojection patch (macroflux) technology. Pharm. Res. 18, 1789-1793.
246. Ameri, M., E. Peters, X. Wang, P. Daddona, and Y.F. Maa (2009) Erythropoietin (EPO) coated microprojection transdermal system: pre-clinical formulation, stability and delivery. AAPS Journal 11(S2), T2245.
247. Daddona, P. (2002) Macroflux® transdermal technology development for the delivery of therapeutic peptides and proteins. Drug Delivery Technology, 2(5), 54-57.
248. Sathyan, G., Y.N. Sun, R. Weyers, P. Daddona, P. Staehr, and S. Gupta (2004) Macroflux® desmopressin transdermal delivery system: pharmacokinetics and pharmacodynamic evaluation in healthy volunteers. AAPS Journal 6(S1), 665.
249. Daddona, P., J. Matriano, J. Mandema, and Y. Maa (2011) Parathyroid hormone (1-34)-coated microneedle patch system: Clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res. 28(1), 159-165.
250. Ameri, M., P.E. Daddona, and Y.F. Maa (2009) Demonstrated solid-state stability of parathyroid hormone PTH (1-34) coated on a novel transdermal microprojection delivery system. Pharm Res. 26, 2454-2463.
251. Zhou, C.P., Y.L. Liu, H.L. Wang, P.X. Zhang, and J.L. Zhang (2010) Transdermal delivery of insulin using microneedle rollers in vivo. Int J Pharm. 392, 127-133.
252. Griss, P., and G. Stemme (2003) Side-opened out-of-plane microneedles for microfluidic transdermal liquid transfer. J. Microelectomech. S. 12(3), 296-301.
253. Stoeber, B., and L. Liepmann (2000) Two-dimensional arrays of out-of-plane needles Proc. ASME MEMS Div. IMECE. 1, 355-359.
254. Wang, P.M., M. Cornwell, J. Hill, and M.R. Prausnitz (2006) Precise microinjection into skin using hollow microneedles, J. Invest. Dermatol. 126, 1080-1087.
255. Sammoura, F., J.J. Kang, Y.M. Heo, S.J. Tae, and L. Liwei (2007) Polymeric microneedle fabrication using a microinjection molding technique. Microsyst. Technol. 13, 517-522.
256. Ovsianikov, A., B. Chichkov, P. Mente, N. Monteiro-Riviere, A. Doraiswamy, and R. Narayan (2007) Two photon polymerization of polymer-ceramic hybrid materials for transdermal drug delivery. Int. J. Appl. Ceramic Tech. 4(1), 22-29.
257. Verbaan, F., S. Bal, D. Van den Berg, W. Groenink, H. Verpoorten, R. Luttge, and J. Bouwstra (2007) Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J. Control. Release 117, 238-245.
258. Verbaan, F.J., S.M. Bal, D.J.B. Van den, J.A. Dijksman, M. Van Hecke, H. Verpoorten, A.B. Van den, R. Luttge, and J.A. Bouwstra (2008) Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J. Control. Release 128, 80-88.
259. Sivamani, R., B. Stoeber, G. Wu, H. Zhai, D. Liepmann, and H. Maibach (2005) Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res. Technol. 11(2), 152-156.
260. Sivamani, R., B. Stoeber, D. Liepmann, and H. Maibach (2009) Microneedle penetration and injection past the stratum corneum in humans. J. Dermatol. Treat 20(3), 156-159.
261. Gardeniers, H., R. Luttge, E. Berenschot, M. de Boer, S. Yeshurun, M. Hefetz, van't R. Oever, and A. Van den Berg (2003) Silicon micromachined hollow microneedles for transdermal liquid transport. J. Microelectomech. S. 12(6), 855-862.
262. Burton, S.A., C.Y. Ng, R. Simmers, C. Moeckly, D. Brandwein, T. Gilbert, N. Johnson, K. Brown, T. Alston, G. Prochnow, K. Siebenaler, and K. Hansen (2011) Rapid intradermal delivery of liquid formulations using a hollow microstructured array. Pharm Res. 28, 31-40.
263. Valla, V. (2010) Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps. Exp Diabetes Res. 178372. Epub 2010.
264. Davis, S., W. Martanto, M. Allen, and M. Prausnitz (2005) Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans. Biomed. Eng. 52(5), 909-915.
265. Nordquist, L., N. Roxhed, P. Griss, and G. Stemme (2007) Novel microneedle patches for active insulin delivery are efficient in maintaining glycaemic control: an initial comparison with subcutaneous administration. Pharm. Res. 24(7), 93-100.
266. Roxhed, N., G. Patrick, and G. Stemme (2008) Membrane-sealed hollow microneedles and related administration schemes for transdermal drug delivery. Biomed. Microdevices. 10, 271-279.
267. Gupta, J., E. Felner, and M. Prausnitz (2009) Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol. Ther. 11(6), 329-337.
268. Miyano, T., Y. Tobinaga, K. Takahiro, Y. Matsuzaki, T. Hitoshi, W. Makoto, and H. Katsumi (2005) Sugar micro needles as transdermic drug delivery. System. Biomed. Microdevices 7(3), 185-188.
269. Kolli, C., and A. Banga (2008) Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm. Res. 25(1), 104-113.
270. Donnelly, R.F., M.J. Garland, D.I.J. Morrow, K. Migalska, R.R.S. Thakur, R. Majithiya, and A.D. Woolfson (2010) Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J. Control. Release 147(3), 333-341.
271. Donnelly, R.F., R. Majithiya, T.R. Singh, D.I. Morrow, M.J. Garland, Y.K. Demir, K. Migalska, E. Ryan, D. Gillen, C.J. Scott, and A.D. Woolfson (2011) Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res. 28(1), 41-57.
272. Kwon, S.Y. (2004) In vitro evaluation of transdermal drug delivery by a microneedle patch, Controlled Release Society 31st Annual Meeting Transactions. TheraJect Inc. no. 115.
273. Vajragupta, O., and S. La-Ong (1994) Synthesis and skin permeation study of lidocaine organic salts. Drug Dev. Ind. Pharm. 20(17), 2671-2684.
274. Park, J.H., S.O. Choi, S. Seo, Y.B. Choy, and M.R. Prausnitz (2010) A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm 76, 282-289.
275. Li, G., A. Badkar, S. Nema, C.S. Kolli, and A.K. Banga (2009) In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int. J. Pharm. 368, 109-115.
276. Li, G., A. Badkar, H. Kalluri, and A. Banga (2010) Microchannels created by sugar and metal microneedles: Characterization by microscopy, macromolecular flux and other techniques. J. Pharm. Sci. 99(4), 1931-1941.
277. Donnelly, R.F., D.I.J. Morrow, R.R.S. Thakur, K. Migalska, P.A. McCarron, C. O'Mahony, and A.D. Woolfson (2009) Processing difficulties and instability of carbohydrate microneedle arrays. Drug Dev. Ind. Pharm. 35, 1242-1254.
278. Park, J.H., M.G. Allen, and M.R. Prausnitz (2005) Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J. Control. Release 104, 51-66.
279. Park, J.H., M.G. Allen, and M.R. Prausnitz (2006) Polymer microneedles for controlled-release drug delivery. Pharm Res. 23(5), 1008-1019.
280. Jae-Ho, O., H.H. Park, D.O. Ki-Young, M. Han, D.H. Hyun, C.G. Kim, C.H. Kim, S.S. Lee, H. Sung-Joo, S.C. Shin, and C.W. Cho (2008) Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur J Pharm Biopharm. 69, 1040-1045.
281. Ito, Y., H. Eiji, S. Atsushi, S. Nobuyuki, and T. Kanji (2006) Feasibility of microneedles for percutaneous absorption of insulin. Euro. J. Pharm. Sci. 29(1), 82-88.
282. Ito, Y., Y. Ohashi, A. Saeki, N. Sugioka, and K. Takada (2008) Antihyperglycemic effect of insulin from self-dissolving micropiles in dogs. Chem. Pharm. Bull. 56(3), 243-246.
283. Ito, Y., J. Yoshmitsu, K. Shiroyama, N. Sugioka, K. Takada (2006) Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J. Drug Target 14(5), 255-261.
284. Ito, Y., A. Saeki, K. Shiroyama, N. Sugioka, and K. Takada (2008) Percutaneous absorption of interferon-alpha by self-dissolving micropiles. J. Drug Target 16(3), 243-249.
285. Ito, Y., Y. Ohashi, K. Shiroyama, N. Sugioka, and K. Takada (2008) Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats. Biol. Pharm. Bull. 31(8), 1631-1633.
286. Ito, Y., R. Hasegawa, K. Fukushima, N. Sugioka, and K. Takada (2010) Self-dissolving micropile array chip as percutaneous delivery system of protein drug. Biol Pharm Bull. 33(4), 683-690.
287. Fukushima, K., A. Ise, H. Morita, R. Hasegawa, Y. Ito, N. Sugioka, and K. Takada (2011) Two-layered dissolving microneedles for percutaneous delivery of peptide/ protein drugs in rats. Pharm. Res. 28(1), 7-21.
288. Vemulapalli, V., Y. Yang, P.M. Friden, and A.K. Banga (2008) Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J. Pharm. Pharmcol. 60, 27-33.
289. Katikaneni, S., A. Badkar, S. Nema, and A.K. Banga (2009) Molecular charge mediated transport of a 13 kD protein across microporated skin. Int. J. Pharm. 378(1-2), 93-100.
290. Vemulapalli, V., H. Kim, S. Davis, P. Friden, and A. Banga (2007) In vivo iontophoretic delivery of salmon calcitonin across microporated skin AAPS J. Available at: www. aapsj.org/abstracts/AM_2007/AAPS2007-003548.pdf (accessed 8 March 2011).
291. Bai, Y., H. Kim, P. Friden, and A. Banga (2009) Transdermal delivery of Alexa Fluor labelled BSA using microneedles and iontophoresis in a hairless rat model AAPS J. Available at: www.aapsj.org/abstracts/AM_2009/AAPS2009-001389.pdf (accessed 8 March 2011).
292. Lanke, S., C. Kolli, J. Strom, and A. Banga (2009) Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation. Int. J. Pharm. 365(1-2), 26-33.
293. Wu, X.M., H. Todo, and K. Sugibayashi (2007) Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis. J. Control. Release 118, 189-195.
294. Qiu, Y., Y. Gao, K. Hu, and F. Li (2008) Enhancement of skin permeation of docetaxel: A novel approach combining microneedle and elastic liposomes. J. Control. Release 129(2), 144-150.
295. Chen, H., H. Zhu, J. Zheng, D. Mou, J. Wan, J. Hang, T. Shi, Y. Zhao, H. Xu, and X. Yang (2009) Iontophoresis-driven penetration of nanovesicles through microneedleinduced skin microchannels for enhancing transdermal delivery of insulin. J. Control. Release 139(1), 63-72.
296. Chen, B., J. Wei, and C. Iliescu (2010) Sonophoretic enhanced microneedles array (SEMA) - Improving the efficiency of transdermal drug delivery. Sensor. Actuat. B-Chem. 145(1), 54-60.
297. Baxter, J., and S. Mitragotri (2006) Needle-free liquid jet injections: mechanisms and applications. Expert Rev Med Devices 3(5), 565-574.
298. Dixit, N., V. Bali, S. Baboota, A. Ahuja, and J. Ali (2007) Iontophoresis - an approach for controlled drug delivery: a review. Curr Drug Deliv. 4(1), 1-10.
299. Donnelly, R., R. Thakur, M. Tunney, D. Morrow, P. McCarron, C. O'Mahony, and D. Woolfson (2009) Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm. Res. 26(11), 2513-2522.
300. Kersten, G., and H. Hirschberg (2007) Needle-free vaccine delivery. Expert Opinion on Drug Delivery 4(5), 459-474.
301. Kendall, M. (2006) Engineering of needle-free physical methods to target epidermal cells for DNA vaccination. Vaccine 24(21), 4651-4656.
302. Lambert, P.H., and P.E. Laurent (2008) Intradermal vaccine delivery: Will new delivery systems transform vaccine administration? Vaccine 26(26), 3197-3208.
303. Giudice, E.L., and J.D. Campbell (2006) Needle-free vaccine delivery. Advanced Drug Delivery Reviews 58(1), 68-89.
304. Huang, C.M. (2007) Topical vaccination: the skin as a unique portal to adaptive immune responses. Seminars in Immunopathology 29(1), 71-80.
305. Hamilton, J.G. (1995) Needle phobia - a neglected diagnosis. Journal of Family Practice 41(2), 169-175.
306. Simonsen, L., A. Kane, J. Lloyd, M. Zaffran, and M. Kane (1999) Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bulletin of the World Health Organization 77(10), 789-800.
307. Laurent, A., F. Mistretta, D. Bottigioli, K. Dahel, C. Goujon, J.F. Nicolas, A. Hennino, and P.E. Laurent (2007) Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine 25(34), 6423-6430.
308. Kim, Y.C., F.S. Quan, R.W. Compans, S.M. Kang, and M.R. Prausnitz (2010) Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. Journal of Controlled Release 142(2), 187-195.
309. Kim, Y.C., F.S. Quan, D.G. Yoo, R.W. Compans, S.M. Kang, and M.R. Prausnitz (2009) Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine 27(49), 6932-6938.
310. Zhu, Q.Y., V.G. Zarnitsyn, L. Ye, Z.Y. Wen, Y.L. Gao, L. Pan, I. Skountzou, H.S. Gill, M.R. Prausnitz, C.L. Yang, and R.W. Compans (2009) Immunization by vaccinecoated microneedle arrays protects against lethal influenza virus challenge. Proceedings of the National Academy of Sciences of the United States of America 106(19), 7968-7973.
311. Pearton, M., S.M. Kang, J.M. Song, Y.C. Kim, F.S. Quan, A. Anstey, M. Ivory, M.R. Prausnitz, R.W. Compans, and J.C. Birchall (2010) Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28(37), 6104-6113.
312. Song, J.M., Y.C. Kim, A.S. Lipatov, M. Pearton, C.T. Davis, D.G. Yoo, K.M. Park, L.M. Chen, F.S. Quan, J.C. Birchall, R.O. Donis, M.R. Prausnitz, R.W. Compans, and S.M. Kang (2010) Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clinical and Vaccine Immunology 17(9), 1381-1389.
313. Kim, Y.C., F.S. Quan, D.G. Yoo, R.W. Compans, S.M. Kang, and M.R. Prausnitz (2010) Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. Journal of Infectious Diseases 201(2), 190-198.
314. Quan, F.S., Y.C. Kim, A. Vunnava, D.G. Yoo, J.M. Song, M.R. Prausnitz, R.W. Compans, and S.M. Kang (2010) Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. Journal of Virology 84(15), 7760-7769.
315. Andrianov, A.K., D.P. DeCollibus, H.A. Gillis, H.H. Kha, A. Marin, M.R. Prausnitz, L.A. Babiuk, H. Townsend, and G. Mutwiri (2009) Poly di(carboxylatophenoxy) phosphazene is a potent adjuvant for intradermal immunization. Proceedings of the National Academy of Sciences of the United States of America 106(45), 18936-18941.
316. Han, M., D.K. Kim, S.H. Kang, H.R. Yoon, B.Y. Kim, S.S. Lee, K.D. Kim, and H.G. Lee (2009) Improvement in antigen-delivery using fabrication of a groovesembedded microneedle array. Sensors and Actuators B-Chemical 137(1), 274-280.
317. Widera, G., J. Johnson, L. Kim, L. Libiran, K. Nyam, P.E. Daddona, and M. Cormier (2006) Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24(10), 1653-1664.
318. Prow, T.W., X.F. Chen, N.A. Prow, G.J.P. Fernando, C.S.E. Tan, A.P. Raphael, D. Chang, M.P. Ruutu, D.W.K. Jenkins, A. Pyke, M.L. Crichton, K. Raphaelli, L.Y.H. Goh, I.H. Frazer, M.S. Roberts, J. Gardner, A.A. Khromykh, A. Suhrbier, R.A. Hall, and M.A.F. Kendall (2010) Nanopatch-targeted skin vaccination against West Nile virus and Chikungunya virus in mice. Small 6(16), 1776-1784.
319. Corbett, H.J., G.J.P. Fernando, X.F. Chen, I.H. Frazer, and M.A.F. Kendall (2010) Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model. Plos One 5(10).
320. Fernando, G.J.P., X.F. Chen, T.W. Prow, M.L. Crichton, E.J. Fairmaid, M.S. Roberts, I.H. Frazer, L.E. Brown, and M.A.F. Kendall (2010) Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery in a mouse model. Plos One 5(4).
321. Ding, Z., F.J. Verbaan, M. Bivas-Benita, L. Bungener, A. Huckriede, D.J. van den Berg, G. Kersten, and J.A. Bouwstra (2009) Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. Journal of Controlled Release 136(1), 71-78.
322. Ding, Z., E. Van Riet, S. Romeijn, G.F.A. Kersten, W. Jiskoot, and J.A. Bouwstra (2009) Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment. Pharmaceutical Research (Dordrecht) 26(7), 1635-1643.
323. Bal, S.M., Z. Ding, G.F.A. Kersten, W. Jiskoot, and J.A. Bouwstra (2010) Microneedlebased transcutaneous immunisation in mice with N-Trimethyl chitosan adjuvanted diphtheria toxoid formulations. Pharmaceutical Research 27(9), 1837-1847.
324. Van Damme, P., F. Oosterhuis-Kafeja, M. Van der Wielen, Y. Almagor, O. Sharon, and Y. Levin (2009) Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27(3), 454-459.
325. Alarcon, J.B., A.W. Hartley, N.G. Harvey, and J.A. Mikszta (2007) Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clinical and Vaccine Immunology 14(4), 375-381.
326. Laurent, P.E., H. Bourhy, M. Fantino, P. Alchas, and J.A. Mikszta (2010) Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine 28(36), 5850-5856.
327. Mikszta, J.A., J.P. Dekker, N.G. Harvey, C.H. Dean, J.M. Brittingham, J. Huang, V.J. Sullivan, B. Dyas, C.J. Roy, and R.G. Ulrich (2006) Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infection and Immunity 74(12), 6806-6810.
328. Sullivan, S.P., D.G. Koutsonanos, M.D. Martin, J.W. Lee, V. Zarnitsyn, S.O. Choi, N. Murthy, R.W. Compans, I. Skountzou, and M.R. Prausnitz (2010) Dissolving polymer microneedle patches for influenza vaccination. Nature Medicine 16(8), 915-U116.
329. Raphael, A.P., T.W. Prow, M.L. Crichton, X.F. Chen, G.I.P. Fernando, and M.A.F. Kendall (2010) Targeted, needle-free vaccinations in skin using multi layered, densely-packed dissolving microprojection arrays. Small 6(16), 1785-1793.
330. Li, G.H., A. Badkar, S. Nema, C.S. Kolli, and A.K. Banga (2009) In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. International Journal of Pharmaceutics 368(1-2), 109-115.
331. Chabri, F., K. Bouris, T. Jones, D. Barrow, A. Hann, C. Allender, K. Brain, and J. Birchall (2004) Microfabricated silicon microneedles for nonviral cutaneous gene delivery. British Journal of Dermatology 150(5), 869-877.
332. Birchall, J., S. Coulman, M. Pearton, C. Allender, K. Brain, A. Anstey, C. Gateley, N. Wilke, and A. Morrissey (2005) Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch microfabricated microneedles. Journal of Drug Targeting 13(7), 415-421.
333. Coulman, S., D. Barrow, A. Anstey, C. Gateley, A. Morrissey, N. Wilke, K. Brain, and J. Birchall (2006) Minimally invasive cutaneous delivey of macromolecules and plasmid DNA via microneedles. Current Drug Delivery 3, 65-75.
334. Pearton, M., C. Allender, K. Brain, A. Anstey, C. Gateley, N. Wilke, A. Morrissey, and J. Birchall (2008) Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharmaceutical Research 25(2), 407-416.
335. Gill, H.S., J. Soderholm, M.R. Prausnitz, and M. Sallberg (2010) Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Therapy 17(6), 811-814.
336. Choi, S.O., J.H. Park, H.S. Gill, Y. Choi, M.G. Allen, and M.R. Prausnitz (2005) Microneedle electrode array for electroporation of skin for gene therapy. Controlled Release Society 32nd Annual Meeting & Exposition Transactions 318.
337. Hooper, J.W., J.W. Golden, A.M. Ferro, and A.D. King (2007) Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 25(10), 1814-1823.
338. Daugimont, L., N. Baron, G. Vandermeulen, N. Pavselj, D. Miklavcic, M.C. Jullien, G. Cabodevila, L.M. Mir, and V. Preat (2010) Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. Journal of Membrane Biology 236(1), 117-125.
339. Donnelly, R.F., D.I.J. Morrow, P.A. McCarron, A.D. Woolfson, A. Morrissey, P. Juzenas, A. Juzeniene, V. Iani, H.O. McCarthy, and J. Moan (2008) Microneedlemediated intradermal delivery of 5-aminolevulinic acid: Potential for enhanced topical photodynamic therapy. Journal of Controlled Release 129(3), 154-162.
340. Mikolajewska, P., R.F. Donnelly, M.J. Garland, D.I.J. Morrow, T.R.R. Singh, V. Iani, J. Moan, and A. Juzeniene (2010) Microneedle pre-treatment of human skin improves 5-aminolevulininc acid (ALA)- and 5-aminolevulinic acid methyl ester (MAL)- induced PpIX production for topical photodynamic therapy without increase in pain or erythema. Pharmaceutical Research 27(10), 2213-2220.
341. Yoo, K.H., J.W. Lee, K. Li, B.J. Kim, and M.N. Kim (2010) Photodynamic therapy with methyl 5-aminolevulinate acid might be ineffective in recalcitrant alopecia totalis regardless of using a microneedle roller to increase skin penetration. Dermatologic Surgery 36(5), 618-622.
342. Clementoni, M.T., M.B-Roscher, and G.S. Munavalli (2010) Photodynamic photorejuvenation of the face with a combination of microneedling, red light, and broadband pulsed light. Lasers in Surgery and Medicine 42(2), 150-159.
343. Donnelly, R.F., D.I.J. Morrow, P.A. McCarron, A.D. Woolfson, A. Morrissey, P. Juzenas, A. Juzeniene, V. Iani, H.O. McCarthy, and J. Moan (2009) Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochemistry and Photobiology 85(1), 195-204.
344. Donnelly, R.F., D.I.J. Morrow, F. Fay, C.J. Scott, Abdelghany S., T.R.R. Singh, M.J. Garland, and A.D. Woolfson (2010) Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers. Photodiagnosis and Photodynamic Therapy 7, 222-231.
345. Zhang, Wei, Jing Gao, Quangang Zhu, Min Zhang, Xueying Ding, Xiaoyu Wang, Xuemei Hou, Wei Fan, Baoyue Ding, Xin Wu, Xiying Wang, and Shen Gao (2010) Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm 402(1-2), 205-212.
346. Coulman, S.A., A. Anstey, C. Gateley, A. Morrissey, P. McLoughlin, C. Allender, and J.C. Birchall (2009) Microneedle mediated delivery of nanoparticles into human skin. International Journal of Pharmaceutics 366(1-2), 190-200.
347. Harvey, A.J., S.A. Kaestner, D.E. Sutter, N.G. Harvey, J.A. Mikszta, and R.J. Pettis (2011) Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs. Pharmaceutical Research DOI: 10.1007/s11095-010-0123-9.
348. Crichton, M.L., A. Ansaldo, X.F. Chen, T.W. Prow, G.J.P. Fernando, and M.A.F. Kendall (2010) The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine. Biomaterials 31(16), 4562-4572.
349. Chuong, C.M., B.J. Nickoloff, P.M. Elias, et al. (2002) What is the 'true' function of skin? Exp. Dermatol 11, 159-187.
350. Wysocki, A.B. (1999) Skin anatomy, physiology, and pathophysiology. Nurs. Clin. North Am 34, 777-797.
351. Henry, S., D.V. McAllister, M.G. Allen, et al. (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 87, 922-925.
352. Coulman, S.A., D. Barrow, A. Anstey, et al. (2006) Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr. Drug Deliv 3, 65-75.
353. Donnelly, R.F., D.I.J. Morrow, P.A. McCarron, et al. (2008) Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Cont Rel 129, 154-162.
354. Donnelly, R.F., D.I.J. Morrow, P.A. McCarron, et al. (2009) Microneedle arrays permit true intradermal delivery of a preformed photosensitiser. Photochem Photobiol 85, 195-204.
355. McAllister, D.V., P.M. Wang, S.P. Davis, et al. (2003) Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies. PNAS 100(24), 13755-13760.
356. Mikszta, J.A., J.P. Dekker, N.G. Harvey, et al. (2006) Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect. Immun 74, 6806-6810.
357. Park, J.H., M.G. Allen, and M.R. Prausnitz (2005) Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Cont Rel 104, 51-66.
358. Teo, M.A., C. Shearwood, K.C. Ng, et al. (2005) In vitro and in vivo characterization of MEMS microneedles. Biomed Microdev 7, 47-52.
359. Kaushik, S., H.H. Allen, D.D. Donald, et al. (2001) Lack of pain associated with microfabricated microneedles. Anesth Analg 92, 502-504.
360. Haq, M.I., E., Smith, D.N. John, et al. (2009) Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 11, 35-47.
361. Damme, P.V., O.K., Froukje, M.W. Van der, et al. (2009) Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 27, 454-459.
362. Wermeling, D.P., S.L. Banks, D.A. Hudson, et al. (2008) Microneedles permit transdermal delivery of a skin-impermeant medication to humans. PNAS. 105(6), 2058-2063.
363. Gupta, J., H.S. Gill, S.N. Andrews, et al. (2011) Kinetics of skin resealing after insertion of microneedles in human subjects. J Cont Rel. Accepted for publication.
364. WHO. Safety of Injections (2004) In Secretariat of the Safe Injection Global Network, vol. 2007. Department of Essential Health Technologies, World Health Organization.
365. Nir, Y.A., P.E. Sabo, et al. (2003) Fear of injections in young adults: prevalence and associations. Am. J. Trop Med. Hyg 68, 341-344.
366. James, A.D., and N.G. Harvey (2003) Minimally invasive systems for transdermal drug delivery. In: Transdermal Drug Delivery (eds Guy RH, Hadgraft J), Marcel Dekker Inc., New York, pp. 126-140.
367. Melzack, R., and P.D. Wall (1988) The Challenge of Pain, 2nd edn,. Basic Books, New York.
368. Melzack, R., and K.L. Casey (1968) Sensory, motivational, and central control determinants of pain: A new conceptual model. In: The Skin Senses (ed. D. Kenshalo), Charles C Thomas, Springfield, IL, pp. 423-443.
369. Jensen, M.P., and I. Karoly (1992) Self-report scales and procedures for assessing pain in adults. In: Handbook of Pain Assessment (eds Turk DC, Melzack R), Guilford Press, New York, pp. 135-151.
370. Bodian, C.A., G. Freedman, S. Hossain, et al. (2001) The visual analog scale for pain clinical significance in postoperative patients. Anesthesiology 95, 1356-1361.
371. DeLoach, L.J., M.S. Higgins, A.B. Caplan, et al. (1998) The visual analog scale in the immediate postoperative period: lntrasubject variability and correlation with a numeric scale. Anesth Analg 86, 102-106.
372. Bal, S.M., J. Caussin, S. Pavel, et al. (2008) In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sc. 35(3), 193-202.
373. Burckhardt, C.S., and K.D. Jones (2003) Adult measures of pain. Arthritis & Rheumatism (Arthritis Care & Research) 49(5), S96-S104.
374. Chapman, C.R., K.L. Case, and R. Dubner, (1985) Pain measurement: an overview. Pain. 22, 1-31.
375. Sivamani, R.K., B. Stoeber, G.C. Wu, et al. (2005) Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res Technol 11(2), 152-156.
376. Shirkhanzadeh, M. (2005) Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalose. J Mater Sci Mater Med 16, 37-45.
377. Miyano, T., Y. Tobinaga, K. Takahiro, et al. (2005) Sugar Micro Needles as Transdermic Drug Delivery System. Biomedical Microdevices 7, 3, 185-188.
378. Smart, W.H., and K. Subramanian (2000) The use of silicon microfabrication technology in painless blood glucose monitoring. Diabetes Technol Ther 2, 549-559.
379. Wang, P.M., M. Cornwell, and M.R. Prausnitz (2005) Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using Microneedles. Diabetes Technol. Ther 7, 131-141.
380. Menon, G.K., K.R. Feingold, and P.M. Elias (1992) Lamellar body secretory response to barrier disruption. J Invest Dermatol 98(3), 279-289.
381. Kalluri, H., and A.K. Banga (2011) Formation and closure of microchannels in skin following microporation. Pharm Res 28, 82-94.
382. Hoffman, P. (2001) Skin disinfection and acupuncture. Acupuncture in Medicine 19, 112-116.
383. Yentur, E.A., N. Luleci, I. Topcu, et al. (2003) Is skin disinfection with 10% povidone iodine sufficient to prevent epidural needle and catheter contamination. Regional Anesthesia and Pain Medicine. 28, 389-393.
384. Elsner, P. (2006) Antimicrobials and the skin physiological and pathological flora. Current Problems in Dermatology 33, 35-41.
385. Sato, S., T. Sakuragi, and K. Dan (1996) Human skin flora as a potential source for epidural abscess. Anaesthesiology 85(6), 1276-1282.
386. Elliott, T.S., H.A. Moss, S.E. Tebbs, et al. (1997) Novel approach to investigative source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 16(3), 210-213.
387. Del Mar, C.B., P.P. Glasziou, et al. (2001) Is isopropyl alcohol swabbing before injection really necessary? Medical Journal of Australia 175, 341-342.
388. Sutton, C.D., S.A. White, R. Edwards, et al. (1999) A prospective controlled trial of the efficacy of isopropyl alcohol wipes before venesection in surgical patients. Ann R Coll Surg Engl 81, 183-186.
389. Donnelly, R.F., T.R.R. Singh, M.M. Tunney, et al. (2009). Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 26(11), 2513-2522.
390. Lushniak, B. (2000) Occupational and environmental medicine; occupational skin diseases. Prim Care 27, 1-16.
391. Moeshell, A. (1997) Workshop on irritant contact dermatitis. Am J Contact Dermatitis. 8, 79-105.
392. Corsini, E., and C.L. Galli (1998) Cytokines and irritant contact dermatitis. Toxicol. Lett. 103, 277-282.
393. Chew, A., and H.I. Maibach (2006) Irritant dermatitis. Archives of Dermatological Research. 298, 552.
394. Agner, T., and J. Serup (1990) Sodium lauryl sulfate for irritant patch testing - a dose-response study using bioengineering methods for determination of skin irritation. J. Invest. Dermatol 95(5), 543-547.
395. Andersen, P.H., and H.I. Maibach (1995) Skin irritation in man - a comparative bioengineering study using improved reflectance spectroscopy. Contact Dermatitis 33(5), 315-322.
396. Berardesca, E., and F. Distante (1994) The modulation of skin irritation. Contact Dermatitis 31, 281-287.
397. Fluhr, J.W., O. Kuss, T. Diepgen, et al. (2001) Testing for irritation with a multifactorial approach: comparison of eight non-invasive measuring techniques on five different irritation types. Br J Dermatol 145(5), 696-703.
398. Pinnagoda, J., R.A. Tupkek, T. Agner, et al. (1999) Guidelines for transepidermal water loss (TEWL) measurement. Contact Dermatitis. 22(3), 164-178.
399. Hadgraft, J., and M.E. Lane (2009) Transepidermal water loss and skin site: A hypothesis. Int J Pharmaceutics 373, 1-3.
400. Berardesca, E., P. Elsner, and H.I. Maibach (1995) Bioengeneering of the Skin: Cutaneous Blood Flow and Erythema. of the Skin: Cutaneous Blood Flow and Erythema.
401. Marks, J.G., P. Elsner, and V.A. DeLeo (2002) Contact and Occupational Dermatology, 3rd edn, Mosby, St Louis.
402. Park, J.H., M.G. Allen, and M.R. Prausnitz (2005) Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery. J Control Release 104, 51-66.
403. Braybrook, J.H. (1997) Biocompatibility. In: Biocompatibility: Assessment of Medical Devices and Materials, Wiley & Sons, Inc., New York, pp. 97-109.
404. Runyan, W.R., and K.E. Bean (1990) Safety of materials. In: Semiconductor Integrated Circuit Processing Technology, Addison-Wesley, New York.
405. Williams, D.F. (1986) Definitions in biomaterials. In: Progress in Biomedical Engineering, March 3-5, Chester, England. Proceedings of a Consensus Conference of the European Society for Biomaterials.
406. ISO 1993-5 (1999) (2nd edition) Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity.
407. USP 30-NF 25 (2007).
408. Kejlova, K., J. Labsky, D. Jirova, et al. (2005) Hydrophilic polymers biocompatibility testing in vitro. Toxicology in vitro 19, 957-962.
409. Ovsianikov, A., B. Chichkov, P. Mente, et al. (2007) Two photon polymerization of polymer-ceramic hybrid materials for transdermal drug delivery. Int J Appl Ceramic Tech. 4(1), 22-29.
410. Changeza, Md., V. Koula, B. Krishna, et al. (2004) Studies on biodegradation and release of gentamicin sulphate from interpenetrating network hydrogels based on poly(acrylic acid) and gelatin: in vitro and in vivo. Biomaterials 25, 139-146.
411. Coury, A.J., R.J. Levy, C.R. Mcmiilin, et al. (1996) Degradation of Materials in the Biological Environment. In: Biomaterial Science (eds Ratner BD, Hoffman AS, Schoen FJ, Lemons JE), Academic Press, London. pp. 243-246.
412. Potts, R.O., and M.L. Francoeur (1990) Lipid biophysics of water loss through the skin. Proc. Natl. Acad. Sci. USA 87, 3871-3873.
413. Beisson, F., M. Aoubala Marull, et al. (2001) Use of the tape stripping technique for directly quantifying esterase activities in human stratum corneum. Analytical Biochemistry 290, 179-185.
414. Egelrud, T. (1992) Stratum corneum chymotryptic enzyme: Evidence of its location in the stratum corneum intercellular space. Eur J Dermatol 2, 50-55.
415. Elias, P., G. Menon, S. Grayson, et al. (1988) Membrane structural alterations in murine stratum corneum: Relationship to the localization of polar lipids and phospholipases. J Invest Dermatol. 91(1), 3-10.
416. Zaikov, G.E. (1985) Quantitative aspects of polymer degradation in the living body. JMS-Rev. Macromol. Chem. Phys C2: 4, 551-597.
417. Enfield, J., M.L. O'Connell, K.J.E. Lawlor, C. O'Mahony, and M. Leahy (2010) In vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. Journal of Biomedical Optics doi: 10.1117/1.3463002.
418. Coulman, S., J. Birchall, and A. Alex (2010) In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography Pharmaceutical Research. DOI: 10.1007/s11095-010-0167.
419. Donnelly, R.F., M.J. Garland, D.I.J. Morrow, K. Migalska, R.R.S. Thakur, R. Majithiya, and A.D. Woolfson (2010) Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. Journal of Controlled Release 147, 333-341.
420. Hamilton, J.G. (1995) Needle phobia: a neglected diagnosis. Journal of Family Practice 41, 169-175.
421. Giudice, E.L., and J.D. Campbell (2006) Needle-free vaccine delivery. Advanced Drug Delivery Reviews 58, 68-89.
422. Kersten, G., and H. Hirschberg (2007) Needle-free vaccine delivery. Expert Opinion on Drug Delivery 4, 459-474.
423. Sekkat, N., A. Naik, Y.N. Kalia, P. Glikfeld and R.H. Guy (2002) Reverse iontophoretic monitoring in premature neonates: Feasibility and potential. Journal of Controlled Release 81, 83-89.
424. Leboulanger, B., R.H. Guy, and M.B. Delgado-Charro (2004) Reverse iontophoresis for non-invasive transdermal monitoring. Physiological Measurement 25, R35-R50.
425. Brunner, M., and H. Derendorf (2006) Clinical microdialysis: Current applications and potential use in drug development. Trends in Analytical Chemistry 25, 674-680.
426. Gartstein, V., V.V. Yuzhakov, G.D. Owens, and F.F. Sherman, (2001) US6256533.
427. Sherman, F.F., and V. Gartstein (2004) US6821281.
428. Prausnitz, M.R., M.G. Allen, S. Henry, D.V. McAllister, D.E. Ackley, and T. Jackson, (2004) US6743211.
429. Sherman, F.F., F. Arias, V. Gartstein, G.D. Owens, M.M. Jevtitch, and C.C Huang (2003) US6591124.
430. Ackley, D.E. (2006) US7027478.
431. Whitson, R.C. (2003) US6603987.
432. Gonnelli, R.R. (2009) US20090043250A1.
433. Frazier, A.B., J.D. Andrade, D.A. Bartholomeusz, and J.D. Brazzle (2009) US20090069697A1.
434. Cho, S.T. (2004) US 20040186419A1.
435. Cormier, M.J.N., and F.T. Theeuwes (2001) US006219574B1.
436. Zimmermann, S., D. Fienbork, B. Stoeber, A. Flounders, and D. Liepmann (2003) A microneedle-based glucose monitor: fabricated on a wafer-level using in-device enzyme immobilization. Proceedings of the 12th International Conference on Solid- State Sensors and Actuators, Boston, 8-12 June.
437. Ahn, C., J. Choi, G. Beaucage, J. Nevin, J. Lee, A. Puntambekar, and J. Lee (2004) Disposable smart lab-on-a-chip for point-of-care clinical diagnostics. Proceedings of the IEEE 92, 154-173.
438. Corrie, S.R., G.J.P. Fernando, M.L. Crichton, M.E.G. Brunck, C.D. Anderson, and M.A.F. Kendall (2010) Surface-modified microprojection arrays for intradermal biomarker capture with low non-specific protein binding. Lab on a Chip 10, 2655-2658.
439. Smart W.H., and K. Subramanian (2000) The use of silicon microfabrication technology in painless blood glucose monitoring. Diabetes Technology and Therapeutics 2, 549-559.
440. Wang P.M., M. Cornwell, and M.R. Prausnitz (2005) Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Technology and Therapeutics 7, 131-141.
441. Banga, A.K. (2011) Microneedles and their applications. Recent Patents on Drug Delivery and Formulation 5(2), 95-132.
442. Yuzhakov, VV, V. Gartstein, and G.D. Owens (2003) US006565532B1.
443. Urtti, A. (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Advanced Drug Delivery Reviews 58, 1131-1135.
444. Patel, S.R., A.S.P. Lin, H.F. Edelhauser, and M.R. Prausnitz (2011) Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharmaceutical Research 28, 166-176.
445. Jiang, J., J.S. Moore, H.F. Edelhauser, and M.R. Prausnitz (2009) Intrascleral drug delivery to the eye using hollow microneedles. Pharmaceutical Research 26, 395-403.
446. Jiang, J., H.S. Gill, D. Ghate, B.E. McCarey, S.R. Patel, H.F. Edelhauser, and M.R. Prausnitz (2007) Coated microneedles for drug delivery to the eye. Investigative Ophthalmology & Visual Science 48, 4038-4043.
447. Morrison J.C., and C.G. Moore (1994) US005364374A.
448. Hilt, J.Z., and N.A. Peppas (2005) Microfabricated drug delivery devices. International Journal of Pharmaceutics 306, 15-23.
449. Yuzhakov, V.V., V. Gartstein, and G.D. Owens (2003) US6565532.
450. http://www.genuinedermaroller.co.uk/ (accessed 14 March 2011).
451. http://www.derma-rollers.com/ (accessed 14 March 2011).
452. http://www.facethefuture.co.uk/shop/genuine-dermaroller/beauty-mouse-bodydermaroller-/ prod_354.html (accessed 14 March 2011).
453. http://www.derma-rollers.com/837/scalp-roller-for-hair-loss (accessed 14 March 2011).
454. http://www.zosanopharma.com/index.php?option=com_content&task=blogcateg ory&id=26&Itemid=169 (accessed 17 January 2011).
455. http://www.nanopass.com (accessed 17 January 2011).
456. http://solutions.3m.com/wps/portal/3M/en_WW/DrugDeliverySystems/ DDSD/technology-solutions/transdermal-technologies/microstructuredtransdermal- systems/ (accessed 17 January 2011).
457. Donnelly, R.F., A.D. Woolfson, P.A. McCarron, D.I.J. Morrow, and A. Morrissey (2007) WO2009040548.
458. Birchall J., R. Clemo, A, Anstey, and D. John (2011) Microneedles in clinical practice - An explanatory study into the views and opinions of healthcare professionals and the public. Pharmaceutical. Research 28: 95-106.
459. Thakur, R.R.S., N.J. Dunne, E. Cunningham, and R.F. Donnelly (2011) Review of patents on microneedle applicators. Recent Patents on Drug Delivery and Formulation 5(1), 11-23.
460. Donnelly R.F., R.R.S. Thakur M.M. Tunney, D.I.J. Morrow, P.A. McCarron, C. O'Mahony, and A.D. Woolfson (2009) Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharmaceutical. Research 26, 2513-2522.
461. Wei-Ze L., H. Mei-Ronga, and Z. Jian-Pinga (2010) Super-short solid silicon microneedles for transdermal drug delivery applications International Journal of Pharmaceutics 389, 122-129.
462. Donnelly, R.F., R. Majithiya, R.R.S. Thakur, D.I.J. Morrow, M.J. Garland, Y.K. Demir, K. Migalska, E. Ryan, D. Gillen, C.J. Scott, and A.D. Woolfson (2011) Design and physicochemical characterisation of optimised polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharmaceutical Research 28, 41-57.